Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine

Kuten Pella, Olga ✉; Hornyák, István [Hornyák, István (vegyészmérnök), szerző] Transzlációs Medicina Intézet (SE / AOK / I); Horváthy, Dénes [Horváthy, Dénes Balázs (radiológia, inter...), szerző] Intervenciós Radiológiai Tanszék (SE / AOK / K); Fodor, Eszter [Fodor, Eszter (orvostudomány), szerző] Sportélettani Kutató Központ (MTSE / SETI); Nehrer, Stefan; Lacza, Zsombor [Lacza, Zsombor (Agyi vérkeringés ...), szerző] Transzlációs Medicina Intézet (SE / AOK / I); Egészségtudományi és Sportorvosi Tanszék (MTSE / SETI)

Angol nyelvű Összefoglaló cikk (Folyóiratcikk) Tudományos
Megjelent: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 23 (18) Paper: 10557 , 21 p. 2022
  • SJR Scopus - Inorganic Chemistry: D1
Azonosítók
Albumin is a constitutional plasma protein, with well-known biological functions, e.g., a nutrient for stem cells in culture. However, albumin is underutilized as a biomaterial in regenerative medicine. This review summarizes the advanced therapeutic uses of albumin, focusing on novel compositions that take advantage of the excellent regenerative potential of this protein. Albumin coating can be used for enhancing the biocompatibility of various types of implants, such as bone grafts or sutures. Albumin is mainly known as an anti-attachment protein; however, using it on implantable surfaces is just the opposite: it enhances stem cell adhesion and proliferation. The anticoagulant, antimicrobial and anti-inflammatory properties of albumin allow fine-tuning of the biological reaction to implantable tissue-engineering constructs. Another potential use is combining albumin with natural or synthetic materials that results in novel composites suitable for cardiac, neural, hard and soft tissue engineering. Recent advances in materials have made it possible to electrospin the globular albumin protein, opening up new possibilities for albumin-based scaffolds for cell therapy. Several described technologies have already entered the clinical phase, making good use of the excellent biological, but also regulatory, manufacturing and clinical features of serum albumin.
Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSLMásolásNyomtatás
2025-03-30 05:15